
GC19811
TAK-041
Also known as 2-(4-oxo-1,2,3-benzotriazin-3-yl)-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]acetamide
TAK-041 is a first-in-class, potent, and selective small-molecule G protein-coupled receptor 139 (GPR139) agonist with an EC50 of 22 nM that is being developed for treating cognitive impairment and negative symptoms associated with schizophrenia
ChemicalCAS1929519-13-0MW392.33FormulaC₁₈H₁₅F₃N₄O₃
- CAS number
- 1929519-13-0
- Molecular weight
- 392.33
- Formula
- C₁₈H₁₅F₃N₄O₃
- Solubility
- DMSO : 100 mg/mL (254·89 mM; Need ultrasonic)
- InChIKey
- JZGLECLGVQRPPI-NSHDSACASA-N
- Catalogue number
- GC19811
- Brand
- GLPBIO
Computed properties PubChem CID 121349608 · XLogP 4 · TPSA 83.4 Ų · H-bond donors 1
- XLogP
- 4
- TPSA
- 83.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 5
- Heavy atoms
- 28
SMILES C[C@@H](C1=CC=C(C=C1)OC(F)(F)F)NC(=O)CN2C(=O)C3=CC=CC=C3N=N2
Computed descriptors from PubChem (CID 121349608), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il